Welcome to our dedicated page for Microvision SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MicroVision's SEC filings document material events for a lidar-based perception company serving automotive, industrial, and security and defense markets. Current reports describe operating results, business updates, investor presentations, and product and market disclosures tied to the company's lidar sensor portfolio and perception software.
Recent filings also record the completed acquisition of certain Luminar lidar sensor business assets, including required historical financial statements and unaudited pro forma financial information. Other disclosures cover senior secured convertible notes due 2028, exchanges and purchases of convertible debt, direct common stock sales to directors and executive officers, Nasdaq-related share issuance considerations, governance matters, and Regulation FD communications.
MicroVision, Inc. filed an 8-K describing several capital markets and listing actions. The company amended its At-The-Market Issuance Sales Agreement with Deutsche Bank, Mizuho, and Craig-Hallum so it can continue selling common stock under a new Form S-3 registration statement. As of June 12, 2026, approximately $42 million of common stock remained available but unsold under this ATM facility.
MicroVision has applied to transfer its listing from The Nasdaq Global Market to The Nasdaq Capital Market to seek an additional 180-day period to regain compliance with Nasdaq’s $1.00 minimum bid price requirement. To regain compliance during that period, the stock must close at or above $1.00 for at least 10 consecutive business days, and there is no assurance the transfer or any additional grace period will be granted.
The company also highlighted an existing proposal for shareholders to approve a potential reverse stock split and announced a business update and interactive shareholder Q&A session scheduled for June 25, 2026 to discuss commercial progress, strategy, and matters related to the 2026 Annual Meeting.
MicroVision, Inc. is registering an at-the-market equity program to offer up to $42,000,000 of common stock pursuant to an amended Sales Agreement with Deutsche Bank Securities Inc., Mizuho Securities USA LLC and Craig-Hallum Capital Group LLC, effective June 12, 2026. The offering may be conducted from time to time through the Sales Agents, who will receive a 3% commission on sales.
The prospectus uses an illustrative price of $0.36 per share (last reported sale on June 11, 2026). Shares outstanding were 344,645,965 as of May 28, 2026; the prospectus shows a pro forma example assuming issuance of 116,666,666 shares (resulting in up to 461,312,631 shares outstanding). The company states proceeds will be used for general corporate purposes and warns of immediate dilution to new investors.
MICROVISION, INC. director and CEO Glen W. DeVos reported a tax-related share disposition. The issuer completed a nondiscretionary sell-to-cover transaction tied to an equity award, withholding and selling 183,233 shares of common stock at a weighted average price of $0.3621 per share, in multiple trades between $0.3509 and $0.3779. After this tax-withholding event, DeVos directly holds 537,937 shares of MicroVision common stock.
MicroVision is asking shareholders to approve key capital-structure changes at its July 10, 2026 virtual annual meeting. Shareholders will vote on electing seven directors, approving share issuance tied to senior secured 2026 Convertible Notes, and authorizing a board-controlled reverse stock split.
The company has $43 million of 2026 Convertible Notes due March 1, 2028, initially convertible at $0.8819 per share, with a current conversion cap of 61,315,971 shares until Proposal 2 is approved. Approval would allow additional share issuance instead of substantial cash redemptions.
Proposal 3 would let the board implement a reverse split between 1‑for‑5 and 1‑for‑15 and simultaneously cut authorized common shares from 510 million to 150 million. MicroVision cites the need to regain compliance with Nasdaq’s $1 minimum bid price and to preserve access to capital while addressing shareholder dilution concerns.
MicroVision, Inc. General Counsel Drew G. Markham reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On June 8, 2026, vested RSUs converted into 118,800 shares of common stock on a unit-for-share basis, and a further 150,000 RSUs were granted.
The filing shows a separate 150,000 RSU award approved under the 2025 Executive Bonus Plan, scheduled to vest in thirds annually through June 6, 2028, contingent on continued employment. On June 10, 2026, 77,905 shares were withheld and sold by the issuer at a weighted average price of $0.3621 per share to satisfy tax obligations.
Following these transactions, Markham directly holds 663,203 shares of MicroVision common stock and 150,000 RSUs. The activity reflects derivative exercises, an RSU grant, and a nondiscretionary, tax-related sell-to-cover event rather than open-market buying or selling.
MicroVision, Inc. CEO Glen W. DeVos reported equity compensation activity on June 8, 2026. He exercised vested restricted stock units (RSUs) to acquire 361,500 shares of common stock on a unit-for-share basis, without paying cash.
On the same date, he was granted 361,500 new RSUs tied to common stock. Following these transactions, DeVos directly holds 721,170 shares of common stock and 361,500 RSUs. These are compensation-related awards rather than open-market purchases or sales.
MicroVision, Inc. filed a current report describing a new strategic collaboration in autonomous industrial equipment. The company has signed a long-term Master Development Agreement, with an initial Program Description dated June 1, 2026, to work with the world’s leading manufacturer of construction and mining equipment.
The partners aim to integrate MicroVision’s lidar and perception technologies into next-generation autonomous hauling solutions, initially using two Iris lidar sensors on each off-highway truck, with potential future use of the Halo sensor. MicroVision views the agreement as validating commercial momentum from its first-quarter asset acquisition and its available sensor inventory, while development, testing, and validation efforts are already underway to support the customer’s future autonomous product roadmap.
MicroVision interim CFO Stephen Hrynewich reported routine equity compensation activity. On June 5, vested restricted stock units converted into 6,000 shares of common stock distributed without payment on a unit-for-share basis. On June 8, 2,017 shares were disposed of in a withholding tax-related, nondiscretionary sell-to-cover transaction completed by the company under the award terms. After these transactions, Hrynewich directly holds 182,497 shares of common stock, and the reported RSU grant has been fully converted.
MICROVISION, INC. General Counsel Drew G. Markham exercised previously granted restricted stock units that vested into 119,880 shares of common stock, converting the RSUs on a unit-for-share basis without cash payment. In connection with this vesting, 35,901 shares were disposed of through a tax-withholding, nondiscretionary sell-to-cover transaction completed by the company under the award terms at a weighted average price of $0.3850–$0.3852 per share. After these compensation-related transactions, Markham directly holds 472,308 shares of common stock, and the specific RSU award referenced in the filing is fully converted.
MICROVISION, INC. director Jada Smith exercised vested restricted stock units, receiving 22,007 shares of common stock on a unit-for-share basis without payment. These shares came from restricted stock units that vested and converted into common stock. After the transaction, she directly holds 176,550 common shares.